Phosphonomethylether compounds as antiviral agents.
Martin
J C
JC
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492.
Hitchcock
M J
MJ
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000077404:Cidofovir; D003587:Cytomegalovirus / Q000187:drug effects / Q000502:physiology*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000882:Haplorhini; D006561:Herpes Simplex / Q000188:drug therapy*; D051379:Mice; D063065:Organophosphonates / Q000494:pharmacology* / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D018139:Simplexvirus / Q000187:drug effects / Q000502:physiology*; D013329:Structure-Activity Relationship
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir